Reference
  1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2021. Available from www.ginasthma.org. Accessed July 2021.
  2. Simpson JL, Rodney S, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006;11(1):54-61.
  3. British Thoracic Society. British guideline on the management of asthma. Thorax. 2014;69 Suppl 1:1-192.
  4. Lougheed MD, Lemiere C, Ducharme FM, Licskai C, Dell SD, Roweet BH, et al. Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J, 2012, 19(2):127-164.
  5. Corren, J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med. 2011;365(12):1088-98.
  6. Ortega HG, Yancey SW, Mayer B, Gunsoy NB, Keene ON, Bleecker ER, et al. Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies. Lancet Respir Med. 2016; 4(7):549–556.
  7. Bruce DL, Patricia JN, Michelle MF, Cloutier MM, Georas SN, Jarjouret NN, et al. Future Research Directions in Asthma. An NHLBI Working Group Report. Am J Respir Crit Care Med. 2015;192(11):1366-72.
  8. Idle JR, Gonzalez FJ. Metabolomics. Cell Metab. 2007;6(5):348-51.
  9. Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev. 2011;40(1):387-426.
  10. Kelly RS, Dahlin A, McGeachie MJ, Qiu W, Sordillo J, Wan ES, et al. Asthma Metabolomics and the Potential for Integrative Omics in Research and the Clinic. Chest. 2017;151(2):262-277.
  11. Liu Y, Zheng J, Zhang HP, Zhang X, Wang L, Wood L, et al. Obesity-Associated Metabolic Signatures Correlate to Clinical and Inflammatory Profiles of Asthma: A Pilot Study. Allergy Asthma Immunol Res. 2018;10(6):628-647.
  12. Plaza V, Crespo A, Giner J, Merino JL, Ramos-Barbón D, Mateus EF, et al. Inflammatory Asthma Phenotype Discrimination Using an Electronic Nose Breath Analyzer. J Investig Allergol Clin Immunol. 2015;25(6):431-7.
  13. Wang G, Wang F, Gibson PG, Guo M, Zhang WJ, Gao P, et al. Severe and uncontrolled asthma in China: a cross-sectional survey from the Australasian Severe Asthma Network. J Thorac Dis. 2017 ;9(5):1333-1344.
  14. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000; 161(1):309-329.
  15. Jia CE, Zhang HP, Lv Y, Liang R, Jiang YQ, Powell H, et al. The Asthma Control Test and Asthma Control Questionnaire for assessing asthma control: systematic review and meta-analysis. J Allergy Clin Immunol. 2013;131:695-703.
  16. Xu KF, Luo XC, Chen Y, Zhang YJ, Li Y, Hu B, et al. The use of Juniper’s asthma quality of life questionnaire in Chinese asthmatics. Zhonghua Nei Ke Za Zhi 2003;42:760-3.
  17. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An official American Thoracic Society/ European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009; 180 (1):59-99.
  18. Wang G, Baines KJ, Fu JJ, Wood LG, Simpson JL, McDonald VM, et al. Sputum mast cell subtypes relate to eosinophilia and corticosteroid response in asthma. Eur Respir J. 2016;47(4):1123-33.
  19. Deng K, Zhang X, Liu Y, Zhang L, Wang G, Feng M, et al. Heterogeneity of Paucigranulocytic Asthma: A Prospective Cohort Study with Hierarchical Cluster Analysis. J Allergy Clin Immunol Pract. 2021;9(6):2344-2355.
  20. Manise M, Holtappels G, Van Crombruggen K, Schleich F, Bachert C, Louis R. Sputum IgE and cytokines in asthma: relationship with sputum cellular profile. PLoS One. 2013;8(3):e58388.
  21. Pedersen F, Holz O, Lauer G, Quintini G, Kiwull-Schöne H, Kirsten AM, et al. Multi-analyte profiling of inflammatory mediators in COPD sputum–the effects of processing. Cytokine. 2015;71(2):401-4.
  22. Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, et al; Human Serum Metabolome (HUSERMET) Consortium. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011;6(7):1060-83.
  23. Contrepois K, Wu S, Moneghetti KJ, Hornburg D, Ahadi S, Tsai MS, et al. Molecular Choreography of Acute Exercise. Cell. 2020;181(5):1112-1130.e16.
  24. Wang J, Zhang T, Shen X, Liu J, Zhao D, Sun Y, et al. Serum metabolomics for early diagnosis of esophageal squamous cell carcinoma by UHPLC-QTOF/MS. Metabolomics. 2016;12(7):116.
  25. Chong J, Soufan O, Li C, Caraus I, Li S, Bourque G, et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucl. Acids Res. 2018;46(W1):W486-W494.
  26. Turi KN, Romick-Rosendale L, Ryckman KK, Hartert TV. A review of metabolomics approaches and their application in identifying causal pathways of childhood asthma. J Allergy Clin Immunol. 2018;141(4):1191-1201.
  27. Brinkman P, Wagener AH, Hekking PP, Bansal AT, Maitland-van der Zee AH, Wang Y, et al; U-BIOPRED Study Group. Identification and prospective stability of electronic nose (eNose)-derived inflammatory phenotypes in patients with severe asthma. J Allergy Clin Immunol. 2019;143(5):1811-1820.e7.
  28. Motta A, Paris D, D’Amato M, Melck D, Calabrese C, Vitale C, et al. NMR metabolomic analysis of exhaled breath condensate of asthmatic patients at two different temperatures. J Proteome Res. 2014;13(12):6107-20.
  29. Wang S, Tang K, Lu Y, Tian Z, Huang Z, Wang M, et al. Revealing the role of glycerophospholipid metabolism in asthma through plasma lipidomics. Clin Chim Acta. 2021;513:34-42.
  30. Pang Z, Wang G, Wang C, Zhang W, Liu J, Wang F. Serum Metabolomics Analysis of Asthma in Different Inflammatory Phenotypes: A Cross-Sectional Study in Northeast China. Biomed Res Int. 2018;2018:2860521.
  31. Panda L, Gheware A, Rehman R, Yadav MK, Jayaraj BS, Madhunapantula SV, et al. Linoleic acid metabolite leads to steroid resistant asthma features partially through NF-κB. Sci Rep. 2017;7(1):9565.
  32. Driver AG, Kukoly CA, Ali S, Mustafa SJ. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis. 1993;148(1):91-7.
  33. Mann JS, Holgate ST, Renwick AG, Cushley MJ. Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma. J Appl Physiol. 1986;61(5):1667-76.
  34. van den Berge M, Polosa R, Kerstjens HA, Postma DS. The role of endogenous and exogenous AMP in asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2004;114(4):737-46.
  35. Berla TE, Angel JE, Himadri S, Baig MS, Khan M, Mathias CB, et al. The Role of Histamine and Histamine Receptors in Mast Cell-Mediated Allergy and Inflammation: The Hunt for New Therapeutic Targets. Frontiers in Immunology. 2018; 9:1873.
  36. Saluja R, Ketelaar ME, Hawro T, Church MK, Maurer M, Nawijn MC. The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders. Mol Immunol. 2015;63(1):80-5.
  37. Metz M, Siebenhaar F, Maurer M. Mast cell functions in the innate skin immune system. Immunobiology. 2008; 213(3):251-260.
  38. Saito H. Mast cell research. Chem Immunol Allergy. 2014;100:165-71.
  39. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev. 1997;77(4):1033-79.
  40. Tatemoto K, Nozaki Y, Tsuda R, Konno S, Tomura K, Furuno M, et al. Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors. Biochem Biophys Res Commun. 2006;349(4):1322-8.
  41. Adams RJ, Fuhlbrigge AL, Finkelstein JA, Weiss ST. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol. 2002;109(4):636-42.
  42. Corren J, Manning BE, Thompson SF, Hennessy S, Strom BL. Rhinitis therapy and the prevention of hospital care for asthma: a case-control study. J Allergy Clin Immunol. 2004;113(3):415-9.
  43. Santangelo F, Cortijo J, Morcillo E. Taurine and the lung: which role in asthma? Adv Exp Med Biol. 2003;526:403-10.
  44. Hofford JM, Milakofsky L, Pell S, Fish JE, Peters SP, Pollice M, et al. Levels of amino acids and related compounds in bronchoalveolar lavage fluids of asthmatic patients. Am J Respir Crit Care Med. 1997;155(2):432-5.
  45. Comhair SA, McDunn J, Bennett C, Fettig J, Erzurum SC, Kalhan SC. Metabolomic Endotype of Asthma. J Immunol. 2015;195(2):643-50.
  46. Bazzano M, Laghi L, Zhu C, Magi GE, Serri E, Spaterna A, et al. Metabolomics of tracheal wash samples and exhaled breath condensates in healthy horses and horses affected by equine asthma. J Breath Res. 2018;12(4):046015.
  47. Taylor SL, Leong LEX, Choo JM, Wesselingh S, Yang IA, Upham JW, et al. Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology. J Allergy Clin Immunol. 2018;141(1):94-103.e15.